Literature DB >> 21353979

Research reporting standards for radioembolization of hepatic malignancies.

Riad Salem1, Robert J Lewandowski, Vanessa L Gates, Charles W Nutting, Ravi Murthy, Steven C Rose, Michael C Soulen, Jean-Francois H Geschwind, Laura Kulik, Yun Hwan Kim, Carlo Spreafico, Marco Maccauro, Lourens Bester, Daniel B Brown, Robert K W Ryu, Daniel Y Sze, William S Rilling, Kent T Sato, Bruno Sangro, Jose Ignacio Bilbao, Tobias F Jakobs, Samer Ezziddin, Suyash Kulkarni, Aniruddha Kulkarni, David M Liu, David Valenti, Philip Hilgard, Gerald Antoch, Stefan P Muller, Hamad Alsuhaibani, Mary F Mulcahy, Marta Burrel, Maria Isabel Real, Stewart Spies, Abdulredha A Esmail, Jean-Luc Raoul, Etienne Garin, Mathew S Johnson, Al B Benson, Ricky A Sharma, Harpreet Wasan, Bieke Lambert, Khairuddin Memon, Andrew S Kennedy, Ahsun Riaz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21353979      PMCID： PMC4337835          DOI： 10.1016/j.jvir.2010.10.029

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  84 in total

1.  Liver anatomy: portal (and suprahepatic) or biliary segmentation.

Authors:  C Couinaud
Journal:  Dig Surg       Date:  1999       Impact factor: 2.588

2.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

3.  Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization.

Authors:  Kent Sato; Robert J Lewandowski; James T Bui; Reed Omary; Russell D Hunter; Laura Kulik; Mary Mulcahy; David Liu; Howard Chrisman; Scott Resnick; Albert A Nemcek; Robert Vogelzang; Riad Salem
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Jul-Aug       Impact factor: 2.740

Review 4.  Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria.

Authors:  Daniel B Brown; Jennifer E Gould; Debra A Gervais; S Nahum Goldberg; Ravi Murthy; Steven F Millward; William S Rilling; Jean-Francois S Geschwind; Riad Salem; Suresh Vedantham; John F Cardella; Michael C Soulen
Journal:  J Vasc Interv Radiol       Date:  2007-12       Impact factor: 3.464

5.  Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies.

Authors:  Michael J Wallace; Ravi Murthy; Paresh P Kamat; Teri Moore; Sujaya H Rao; Joe Ensor; Sanjay Gupta; Kamran Ahrar; David C Madoff; Stephen E McRae; Marshall E Hicks
Journal:  J Vasc Interv Radiol       Date:  2007-12       Impact factor: 3.464

Review 6.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

7.  Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.

Authors:  Ahsun Riaz; Vanessa L Gates; Bassel Atassi; Robert J Lewandowski; Mary F Mulcahy; Robert K Ryu; Kent T Sato; Talia Baker; Laura Kulik; Ramona Gupta; Michael Abecassis; Al B Benson; Reed Omary; Laura Millender; Andrew Kennedy; Riad Salem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

8.  Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation.

Authors:  Ahsun Riaz; Khairuddin Memon; Frank H Miller; Paul Nikolaidis; Laura M Kulik; Robert J Lewandowski; Robert K Ryu; Kent T Sato; Vanessa L Gates; Mary F Mulcahy; Talia Baker; Ed Wang; Ramona Gupta; Ritu Nayar; Al B Benson; Michael Abecassis; Reed Omary; Riad Salem
Journal:  J Hepatol       Date:  2010-10-23       Impact factor: 25.083

9.  Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Authors:  Laura M Kulik; Brian I Carr; Mary F Mulcahy; Robert J Lewandowski; Bassel Atassi; Robert K Ryu; Kent T Sato; Al Benson; Albert A Nemcek; Vanessa L Gates; Michael Abecassis; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 10.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799
View more
  61 in total

Review 1.  Radioembolization for primary and metastatic liver cancer.

Authors:  Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Ahsun Riaz; Mary F Mulcahy; Riad Salem
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

2.  Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.

Authors:  Andrew C Gordon; William J Gradishar; Virginia G Kaklamani; Avesh J Thuluvath; Robert K Ryu; Kent T Sato; Vanessa L Gates; Riad Salem; Robert J Lewandowski
Journal:  J Vasc Interv Radiol       Date:  2014-08-22       Impact factor: 3.464

3.  Is dual-phase C-arm CBCT sufficiently accurate for the diagnosis of colorectal cancer liver metastasis during liver intra-arterial treatment?

Authors:  Olivier Pellerin; Helena Pereira; Claire Van Ngoc Ty; Nadia Moussa; Costantino Del Giudice; Simon Pernot; Carole Déan; Gilles Chatellier; Marc Sapoval
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

Review 4.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 5.  Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.

Authors:  Julien Edeline; Marine Gilabert; Etienne Garin; Eveline Boucher; Jean-Luc Raoul
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

6.  Radioembolization with (90)Y-loaded microspheres: high clinical impact of treatment simulation with MAA-based dosimetry.

Authors:  Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07       Impact factor: 9.236

7.  Proving Value in Radiology: Experience Developing and Implementing a Shareable Open Source Registry Platform Driven by Radiology Workflow.

Authors:  Judy Wawira Gichoya; Marc D Kohli; Paul Haste; Elizabeth Mills Abigail; Matthew S Johnson
Journal:  J Digit Imaging       Date:  2017-10       Impact factor: 4.056

Review 8.  Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives.

Authors:  Cristina Mosconi; Alberta Cappelli; Cinzia Pettinato; Rita Golfieri
Journal:  World J Hepatol       Date:  2015-04-18

9.  Evaluation of hepatic tumor response to yttrium-90 radioembolization therapy using texture signatures generated from contrast-enhanced CT images.

Authors:  Rebekah H Gensure; David J Foran; Vincent M Lee; Vyacheslav M Gendel; Salma K Jabbour; Darren R Carpizo; John L Nosher; Lin Yang
Journal:  Acad Radiol       Date:  2012-07-26       Impact factor: 3.173

10.  Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies.

Authors:  John D Roberson Ii; Andrew M McDonald; Craig J Baden; Chee Paul Lin; Rojymon Jacob; Omer L Burnett Iii
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.